Home/Filings/4/0001209191-23-051408
4//SEC Filing

Biller Jonathan 4

Accession 0001209191-23-051408

CIK 0000875320other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:07 PM ET

Size

6.3 KB

Accession

0001209191-23-051408

Insider Transaction Report

Form 4
Period: 2023-09-29
Biller Jonathan
EVP and Chief Legal Officer
Transactions
  • Tax Payment

    Common Stock

    2023-09-29$350.72/sh408$143,09411,179 total
  • Sale

    Common Stock

    2023-10-02$346.76/sh610$211,52410,569 total
Footnotes (1)
  • [F1]Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2023.

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001744749

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:07 PM ET
Size
6.3 KB